Thank you for reading the news about 150 migrants storm border with Spain’s Melilla enclave and now with the details
Jeddah - Yasmine El Tohamy - MOSCOW: A candidate COVID-19 vaccine known as EpiVacCorona, Russia’s second to be registered, proved “100 percent effective” in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve thousands of participants and a placebo group as a comparison.
“The effectiveness of the vaccine is made up of its immunological effectiveness and preventative effectiveness,” the TASS news agency reported, citing Rospotrebnadzor.
“According to results of the first and second phases of clinical trials, the immunological effectiveness of the EpiVacCorona vaccine is 100 percent.”
The Phase I and II studies tested the safety, reactogenicity and immunogenicity of the potential vaccine in 100 people aged 18-60, according to the state trials register.
Russia began testing EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November.
Earlier that month, Moscow said its other approved vaccine, Sputnik V, was 92 percent effective at protecting people from COVID-19 based on interim results.
Russia has said it can inoculate 60 percent of its population against COVID-19 this year, and although the Sputnik V vaccine has been readily available in Moscow, the rollout across the country has been slow.
Russian President Vladimir Putin has ordered mass vaccinations to start this week.
EpiVacCorona will be used in mass vaccinations from March, Deputy Prime Minister Tatiana Golikova told the Interfax news agency.
Russia has reported 3,612,800 coronavirus cases, the world’s fourth-highest total. Its death toll from the virus stands at 66,623.
These were the details of the news 150 migrants storm border with Spain’s Melilla enclave for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Arab News and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.